And I think in the short term clinical trials would properly be done with mesenchymal stem cells delivered intravenously. 我認為，從短期來講，對於靜脈輸注間充質幹細胞開展臨床試驗是沒有問題的。
Mesenchymal stem cells help repair damaged tissue and organs by renewing injured cells. 間充質幹細胞通過更新受損細胞，修復受損的組織和器官。
滬公網安備 31011502000490號
電信業務許可證編號：滬B2-20190700
